FHH-Chr 2BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
10 |
|
116.38 |
breaths/min |
6.91 |
21.84 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14927 |
381 |
FHH-Chr 2BN/Mcwi |
serum total cholesterol level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77 days-91 days |
8 |
|
79.25 |
mg/dl |
3.54 |
10.03 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37089 |
401 |
FHH-Chr 2BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
|
0.23 |
ml |
0.02 |
0.05 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
15384 |
381 |
FHH-Chr 2BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
female |
80 days-99 days |
7 |
|
88.33 |
mg/d |
17.59 |
46.54 |
automated urine total protein analysis |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52101 |
482 |
FHH-Chr 2BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
male |
80 days-99 days |
4 |
|
0.3 |
mg/dl |
0.06 |
0.12 |
radioimmunoassay |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52269 |
482 |
FHH-Chr 2BN/Mcwi |
respiration rate |
air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
10 |
|
156.15 |
breaths/min |
9.77 |
30.91 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14781 |
381 |
FHH-Chr 2BN/Mcwi |
respiration rate |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
10 |
|
163.82 |
breaths/min |
9.3 |
29.41 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16903 |
381 |
FHH-Chr 2BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82 days-99 days |
10 |
|
37.38 |
degrees C |
0.24 |
0.77 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
19061 |
381 |
FHH-Chr 2BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77 days-91 days |
8 |
|
142.38 |
mmol/l |
0.82 |
2.33 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36493 |
401 |
FHH-Chr 2BN/Mcwi |
serum calcium level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77 days-91 days |
8 |
|
9.21 |
mg/dl |
0.07 |
0.19 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36616 |
401 |
FHH-Chr 2BN/Mcwi |
respiration rate |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
10 |
|
171.76 |
breaths/min |
14.25 |
45.06 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18252 |
381 |
FHH-Chr 2BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49 days-63 days |
10 |
|
0.73 |
g |
0.04 |
0.11 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49052 |
461 |
FHH-Chr 2BN/Mcwi |
time to onset of heart contraction |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
male |
49 days-63 days |
8 |
|
993.63 |
s |
19.12 |
54.07 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
50111 |
461 |
FHH-Chr 2BN/Mcwi |
time to peak heart contraction |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
10 |
|
1256.8 |
s |
42.07 |
133.05 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
50214 |
461 |
FHH-Chr 2BN/Mcwi |
serum albumin level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
male |
77 days-91 days |
8 |
|
3.63 |
g/dl |
0.06 |
0.17 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42225 |
401 |
FHH-Chr 2BN/Mcwi |
serum sodium level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
female |
77 days-91 days |
8 |
|
140.63 |
mmol/l |
0.92 |
2.62 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39375 |
401 |
FHH-Chr 2BN/Mcwi |
serum aspartate aminotransferase activity level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77 days-91 days |
8 |
|
97.0 |
U/l |
2.19 |
6.19 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42762 |
401 |
FHH-Chr 2BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77 days-91 days |
8 |
|
104.75 |
mmol/l |
0.45 |
1.28 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39993 |
401 |
FHH-Chr 2BN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
77 days-91 days |
8 |
|
18.5 |
mmol/l |
2.44 |
6.91 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
43134 |
401 |
FHH-Chr 2BN/Mcwi |
fractional change in blood vessel diameter per unit change in intravascular pressure |
Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
blood vessel distensibility trait |
female |
77 days-91 days |
9 |
|
0.03 |
mmHg-1 |
0.0 |
0.01 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59345 |
526 |
FHH-Chr 2BN/Mcwi |
serum phosphate level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
77 days-91 days |
8 |
|
9.45 |
mg/dl |
0.27 |
0.77 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37586 |
401 |
FHH-Chr 2BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
77 days-91 days |
8 |
|
42.88 |
U/l |
3.06 |
8.66 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37694 |
401 |
FHH-Chr 2BN/Mcwi |
methylene blue to FAPGG metabolism-surface area product ratio |
methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
9 |
|
0.38 |
null |
0.03 |
0.09 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59760 |
526 |
FHH-Chr 2BN/Mcwi |
lung dry weight to body weight ratio |
air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
lung mass |
female |
77 days-91 days |
10 |
|
1.87 |
g/kg |
0.02 |
0.08 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59644 |
526 |
FHH-Chr 2BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
male |
77 days-91 days |
10 |
|
0.94 |
g/kg |
0.03 |
0.1 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59457 |
526 |
FHH-Chr 2BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77 days-91 days |
8 |
|
39.51 |
% |
1.32 |
3.73 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41289 |
401 |
FHH-Chr 2BN/Mcwi |
blood lymphocyte count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77 days-91 days |
8 |
|
5.18 |
x 1000 cells/ul |
0.62 |
1.75 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41495 |
401 |
FHH-Chr 2BN/Mcwi |
left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
8 |
|
83.29 |
mmHg |
4.9 |
13.85 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45496 |
461 |
FHH-Chr 2BN/Mcwi |
heart rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
8 |
|
212.35 |
beats/min |
14.27 |
40.37 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47574 |
461 |
FHH-Chr 2BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
male |
77 days-91 days |
8 |
|
42.44 |
% |
1.18 |
3.34 |
microhematocrit tube assay with visual assessment |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57490 |
526 |
FHH-Chr 2BN/Mcwi |
percent change in left ventricular systolic blood pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
62.73 |
% |
3.46 |
9.15 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48743 |
461 |
FHH-Chr 2BN/Mcwi |
maximum contractile force per wet weight of aorta |
potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
9 |
|
1.89 |
g/mg |
0.16 |
0.48 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55766 |
522 |
FHH-Chr 2BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77 days-91 days |
9 |
|
0.32 |
null |
0.02 |
0.06 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57888 |
526 |
FHH-Chr 2BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77 days-91 days |
10 |
|
187.6 |
g |
5.7 |
18.1 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58341 |
526 |
FHH-Chr 2BN/Mcwi |
fractional change in blood vessel diameter per unit change in intravascular pressure |
air oxygen content (12 %) (for 14 days) then Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
blood vessel distensibility trait |
female |
77 days-91 days |
9 |
|
0.03 |
mmHg-1 |
0.0 |
0.01 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58476 |
526 |
FHH-Chr 2BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
9 |
|
-7.71 |
null |
0.11 |
0.32 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56083 |
522 |
FHH-Chr 2BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
9 |
|
0.02 |
umol/l |
0.01 |
0.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54668 |
522 |
FHH-Chr 2BN/Mcwi |
left ventricular diastolic blood pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
9 |
|
5.52 |
mmHg |
0.46 |
1.39 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47184 |
461 |
FHH-Chr 2BN/Mcwi |
left ventricular diastolic blood pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
8 |
|
5.07 |
mmHg |
0.58 |
1.65 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47189 |
461 |
FHH-Chr 2BN/Mcwi |
percent change in arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
25.13 |
% |
1.46 |
4.14 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47069 |
461 |
FHH-Chr 2BN/Mcwi |
left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
8 |
|
98.94 |
mmHg |
5.65 |
15.97 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
44807 |
461 |
FHH-Chr 2BN/Mcwi |
percent change in tidal volume |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
10 |
|
100.7 |
% |
8.57 |
27.11 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
53875 |
381 |
FHH-Chr 2BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
male |
82 days-99 days |
10 |
|
192.8 |
g |
10.2 |
32.2 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Dyets |
17809 |
381 |
FHH-Chr 2BN/Mcwi |
serum alkaline phosphatase activity level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
77 days-91 days |
8 |
|
360.63 |
U/l |
8.02 |
22.67 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36371 |
401 |
FHH-Chr 2BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
female |
80 days-99 days |
6 |
|
12.48 |
mEq/d |
2.12 |
5.19 |
flame atomic emission spectrometry |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52787 |
482 |
FHH-Chr 2BN/Mcwi |
heart rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
7 |
|
155.46 |
beats/min |
14.13 |
37.38 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45135 |
461 |
FHH-Chr 2BN/Mcwi |
left ventricular systolic blood pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
9 |
|
119.64 |
mmHg |
8.17 |
24.5 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45716 |
461 |
FHH-Chr 2BN/Mcwi |
left ventricular diastolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
6 |
|
39.97 |
mmHg |
6.63 |
16.24 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47688 |
461 |
FHH-Chr 2BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
female |
49 days-63 days |
8 |
|
135.1 |
g |
4.7 |
13.2 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47791 |
461 |
FHH-Chr 2BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
56.75 |
% |
5.32 |
14.08 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46058 |
461 |
FHH-Chr 2BN/Mcwi |
body temperature |
air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
male |
82 days-99 days |
10 |
|
37.39 |
degrees C |
0.15 |
0.48 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16564 |
381 |
FHH-Chr 2BN/Mcwi |
plasma creatinine level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
77 days-91 days |
8 |
|
0.36 |
mg/dl |
0.03 |
0.09 |
automated plasma creatinine analysis |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39563 |
401 |
FHH-Chr 2BN/Mcwi |
mean corpuscular hemoglobin concentration |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77 days-91 days |
8 |
|
31.89 |
g/dl |
0.15 |
0.41 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39764 |
401 |
FHH-Chr 2BN/Mcwi |
body weight |
air oxygen content (12 %) (for 14 days) |
PhysGen Cardiac data |
body mass |
female |
49 days-63 days |
10 |
|
103.6 |
g |
4.3 |
13.5 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49496 |
461 |
FHH-Chr 2BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77 days-91 days |
8 |
|
25.5 |
mmol/l |
2.15 |
6.07 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42993 |
401 |
FHH-Chr 2BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
77 days-91 days |
8 |
|
77.0 |
mg/dl |
2.9 |
8.19 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38420 |
401 |
FHH-Chr 2BN/Mcwi |
heart left ventricle infarction weight to total heart left ventricle weight ratio |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours) |
PhysGen Cardiac data |
heart left ventricle integrity trait |
female |
49 days-63 days |
8 |
|
10.59 |
% |
3.35 |
9.48 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49685 |
461 |
FHH-Chr 2BN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
male |
77 days-91 days |
8 |
|
0.31 |
x 1000 cells/ul |
0.07 |
0.21 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40297 |
401 |
FHH-Chr 2BN/Mcwi |
left ventricular systolic blood pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
8 |
|
77.32 |
mmHg |
3.65 |
10.32 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49875 |
461 |
FHH-Chr 2BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77 days-91 days |
8 |
|
12.88 |
g/dl |
0.46 |
1.3 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40089 |
401 |
FHH-Chr 2BN/Mcwi |
heart rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
9 |
|
200.32 |
beats/min |
12.22 |
36.65 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47569 |
461 |
FHH-Chr 2BN/Mcwi |
dose of methacholine at which pulmonary conductance is half its pretreatment value |
methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours) |
PhysGen Lung data |
pulmonary ventilation trait |
female |
77 days-91 days |
4 |
|
3.54 |
mg/kg |
1.04 |
2.08 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59152 |
526 |
FHH-Chr 2BN/Mcwi |
time to onset of heart contraction |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
female |
49 days-63 days |
6 |
|
929.67 |
s |
48.09 |
117.81 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
50106 |
461 |
FHH-Chr 2BN/Mcwi |
mean corpuscular volume |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77 days-91 days |
8 |
|
56.98 |
fl |
0.36 |
1.02 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38737 |
401 |
FHH-Chr 2BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77 days-91 days |
8 |
|
42.44 |
% |
1.18 |
3.34 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41305 |
401 |
FHH-Chr 2BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
10 |
|
111.18 |
breaths/min |
7.1 |
22.46 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14922 |
381 |
FHH-Chr 2BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
female |
80 days-99 days |
5 |
|
0.4 |
ng/ml/h |
0.07 |
0.16 |
radioimmunoassay |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52885 |
482 |
FHH-Chr 2BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
female |
80 days-99 days |
5 |
|
0.24 |
mg/dl |
0.02 |
0.05 |
radioimmunoassay |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52250 |
482 |
FHH-Chr 2BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
male |
80 days-99 days |
5 |
|
1.34 |
mEq/d |
0.07 |
0.15 |
flame atomic emission spectrometry |
|
0 |
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52318 |
482 |
FHH-Chr 2BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
female |
80 days-99 days |
7 |
|
24.31 |
mg/d |
6.0 |
15.88 |
radioimmunoassay |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52393 |
482 |
FHH-Chr 2BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
male |
80 days-99 days |
5 |
|
433.8 |
beats/min |
7.27 |
16.25 |
vascular fluid filled catheter |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52510 |
482 |
FHH-Chr 2BN/Mcwi |
tidal volume |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
|
0.23 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
13910 |
381 |
FHH-Chr 2BN/Mcwi |
respiration rate |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
10 |
|
154.33 |
breaths/min |
11.4 |
36.04 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
17103 |
381 |
FHH-Chr 2BN/Mcwi |
minute ventilation |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
|
47.63 |
ml/min |
2.6 |
8.22 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14487 |
381 |
FHH-Chr 2BN/Mcwi |
percent change in ventilation |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
%change=VE during7-9 min hypercapnia/control during standard conditions |
191.57 |
% |
16.71 |
52.84 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14185 |
381 |
FHH-Chr 2BN/Mcwi |
minute ventilation |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
|
45.69 |
ml/min |
2.99 |
9.46 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20748 |
381 |
FHH-Chr 2BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
female |
77 days-91 days |
8 |
|
5.03 |
g/dl |
0.14 |
0.4 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37185 |
401 |
FHH-Chr 2BN/Mcwi |
percent change in ventilation |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
%change=VE during7-9 min hypercapnia/control during standard conditions |
126.84 |
% |
6.0 |
18.97 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18530 |
381 |
FHH-Chr 2BN/Mcwi |
serum calcium level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
female |
77 days-91 days |
8 |
|
9.21 |
mg/dl |
0.17 |
0.47 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36611 |
401 |
FHH-Chr 2BN/Mcwi |
absolute change in body temperature |
air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
female |
82 days-99 days |
10 |
|
0.29 |
degrees C |
0.12 |
0.37 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20296 |
381 |
FHH-Chr 2BN/Mcwi |
absolute change in body temperature |
air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
male |
82 days-99 days |
10 |
|
0.13 |
degrees C |
0.12 |
0.37 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20301 |
381 |
FHH-Chr 2BN/Mcwi |
time to onset of heart contraction |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
female |
49 days-63 days |
10 |
|
997.6 |
s |
39.86 |
126.04 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49286 |
461 |
FHH-Chr 2BN/Mcwi |
heart left ventricle infarction weight to total heart left ventricle weight ratio |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours) |
PhysGen Cardiac data |
heart left ventricle integrity trait |
male |
49 days-63 days |
8 |
|
8.19 |
% |
2.82 |
7.98 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49388 |
461 |
FHH-Chr 2BN/Mcwi |
percent change in ventilation |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
%change=VE during 2-3 min hypercapnia/control during standard conditions |
199.43 |
% |
15.32 |
48.44 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
19198 |
381 |
FHH-Chr 2BN/Mcwi |
percent change in ventilation |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
10 |
%change=VE during 2-3 min hypercapnia/control during standard conditions |
180.35 |
% |
14.68 |
46.43 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
19203 |
381 |
FHH-Chr 2BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77 days-91 days |
8 |
|
88.5 |
U/l |
7.11 |
20.11 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42404 |
401 |
FHH-Chr 2BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
77 days-91 days |
8 |
|
1.22 |
x 1000 cells/ul |
0.14 |
0.39 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38899 |
401 |
FHH-Chr 2BN/Mcwi |
serum bicarbonate level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
77 days-91 days |
8 |
|
16.75 |
mmol/l |
0.65 |
1.83 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42049 |
401 |
FHH-Chr 2BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
77 days-91 days |
8 |
|
0.09 |
mg/dl |
0.01 |
0.02 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42870 |
401 |
FHH-Chr 2BN/Mcwi |
blood neutrophil count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
77 days-91 days |
8 |
|
1.01 |
x 1000 cells/ul |
0.31 |
0.88 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
43211 |
401 |
FHH-Chr 2BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
77 days-91 days |
8 |
|
24.75 |
mmol/l |
1.81 |
5.12 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42977 |
401 |
FHH-Chr 2BN/Mcwi |
mean corpuscular hemoglobin concentration |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77 days-91 days |
8 |
|
32.25 |
g/dl |
0.15 |
0.41 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39769 |
401 |
FHH-Chr 2BN/Mcwi |
dose of methacholine at which pulmonary conductance is half its pretreatment value |
air oxygen content (12 %) (for 14 days) then methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours) |
PhysGen Lung data |
pulmonary ventilation trait |
male |
77 days-91 days |
9 |
|
2.57 |
mg/kg |
0.74 |
2.22 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58898 |
526 |
FHH-Chr 2BN/Mcwi |
body weight |
air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
body mass |
female |
77 days-91 days |
10 |
|
128.9 |
g |
4.2 |
13.3 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59049 |
526 |
FHH-Chr 2BN/Mcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
female |
77 days-91 days |
8 |
|
3.75 |
g/dl |
0.09 |
0.26 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40394 |
401 |
FHH-Chr 2BN/Mcwi |
percent change in respiration rate |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
10 |
|
142.23 |
% |
7.32 |
23.14 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
53624 |
381 |
FHH-Chr 2BN/Mcwi |
hematocrit |
air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
male |
77 days-91 days |
8 |
|
56.6 |
% |
1.01 |
2.84 |
microhematocrit tube assay with visual assessment |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59249 |
526 |
FHH-Chr 2BN/Mcwi |
serum alanine aminotransferase activity level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77 days-91 days |
8 |
|
46.63 |
U/l |
1.38 |
3.89 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40706 |
401 |
FHH-Chr 2BN/Mcwi |
fractional change in blood vessel diameter per unit change in intravascular pressure |
Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
blood vessel distensibility trait |
male |
77 days-91 days |
8 |
|
0.03 |
mmHg-1 |
0.01 |
0.02 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59361 |
526 |
FHH-Chr 2BN/Mcwi |
total white blood cell count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77 days-91 days |
8 |
|
7.41 |
x 1000 cells/ul |
1.54 |
4.35 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40913 |
401 |
FHH-Chr 2BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77 days-91 days |
8 |
|
10.9 |
mg/dl |
1.34 |
3.78 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37814 |
401 |
FHH-Chr 2BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
77 days-91 days |
8 |
|
10.29 |
mg/dl |
1.35 |
3.82 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37830 |
401 |
FHH-Chr 2BN/Mcwi |
serum potassium level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
male |
77 days-91 days |
7 |
|
5.1 |
mmol/l |
0.17 |
0.46 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38058 |
401 |
FHH-Chr 2BN/Mcwi |
percent change in left ventricular developed pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
6 |
post-ischemic value/pre-ischemic value x 100% |
20.8 |
% |
3.0 |
7.36 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48514 |
461 |
FHH-Chr 2BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
77 days-91 days |
8 |
|
53.84 |
fl |
0.35 |
1.0 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38634 |
401 |
FHH-Chr 2BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77 days-91 days |
8 |
|
52.46 |
fl |
0.31 |
0.87 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38650 |
401 |
FHH-Chr 2BN/Mcwi |
plasma anion gap |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
female |
77 days-91 days |
8 |
|
20.63 |
mmol/l |
0.98 |
2.77 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38248 |
401 |
FHH-Chr 2BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77 days-91 days |
8 |
|
8.09 |
x 10E6 cells/ul |
0.25 |
0.7 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41972 |
401 |
FHH-Chr 2BN/Mcwi |
heart wet weight |
air oxygen content (12 %) (for 14 days) |
PhysGen Cardiac data |
heart mass |
female |
49 days-63 days |
10 |
|
0.79 |
g |
0.05 |
0.16 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45392 |
461 |
FHH-Chr 2BN/Mcwi |
heart wet weight |
air oxygen content (12 %) (for 14 days) |
PhysGen Cardiac data |
heart mass |
male |
49 days-63 days |
9 |
|
0.87 |
g |
0.07 |
0.2 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45397 |
461 |
FHH-Chr 2BN/Mcwi |
left ventricular developed pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
8 |
|
131.27 |
mmHg |
9.31 |
26.33 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48616 |
461 |
FHH-Chr 2BN/Mcwi |
tidal volume |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
|
0.32 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16460 |
381 |
FHH-Chr 2BN/Mcwi |
methylene blue to FAPGG metabolism-surface area product ratio |
air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
9 |
|
0.48 |
null |
0.04 |
0.11 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58100 |
526 |
FHH-Chr 2BN/Mcwi |
methylene blue metabolism-surface area product without auto-oxidation |
methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
8 |
|
23.25 |
ml/min/kg |
1.91 |
5.39 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58626 |
526 |
FHH-Chr 2BN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
9 |
|
219.8 |
g |
6.0 |
18.0 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55177 |
522 |
FHH-Chr 2BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
-6.75 |
null |
0.07 |
0.22 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
56893 |
522 |
FHH-Chr 2BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
8 |
|
2.59 |
ml/min/g |
0.2 |
0.56 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
44710 |
461 |
FHH-Chr 2BN/Mcwi |
left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
6 |
|
41.56 |
mmHg |
7.41 |
18.16 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47898 |
461 |
FHH-Chr 2BN/Mcwi |
left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
8 |
|
46.28 |
mmHg |
3.36 |
9.51 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47903 |
461 |
FHH-Chr 2BN/Mcwi |
heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
6 |
|
240.63 |
beats/min |
14.08 |
34.48 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48184 |
461 |
FHH-Chr 2BN/Mcwi |
percent change in left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
6 |
post-ischemic value/pre-ischemic value x 100% |
89.5 |
% |
12.36 |
30.28 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
44905 |
461 |
FHH-Chr 2BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
6 |
post-ischemic value/pre-ischemic value x 100% |
55.6 |
% |
5.26 |
12.88 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46053 |
461 |
FHH-Chr 2BN/Mcwi |
left ventricular developed pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
7 |
|
22.6 |
mmHg |
5.69 |
15.05 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45262 |
461 |
FHH-Chr 2BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
3 |
|
0.24 |
IU/g |
0.08 |
0.14 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47284 |
461 |
FHH-Chr 2BN/Mcwi |
percent change in tidal volume |
air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
10 |
|
96.69 |
% |
7.51 |
23.73 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
53976 |
381 |
FHH-Chr 2BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
10 |
|
0.25 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
17974 |
381 |
FHH-Chr 2BN/Mcwi |
minute ventilation |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
10 |
|
60.56 |
ml/min |
8.11 |
25.63 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14492 |
381 |
FHH-Chr 2BN/Mcwi |
tidal volume |
air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
|
0.23 |
ml |
0.02 |
0.05 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
15220 |
381 |
FHH-Chr 2BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77 days-91 days |
8 |
|
32.94 |
g/dl |
0.15 |
0.43 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37331 |
401 |
FHH-Chr 2BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
male |
80 days-99 days |
5 |
|
17.74 |
mEq/d |
4.06 |
9.07 |
flame atomic emission spectrometry |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52806 |
482 |
FHH-Chr 2BN/Mcwi |
percent change in arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
33.83 |
% |
4.05 |
12.15 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47064 |
461 |
FHH-Chr 2BN/Mcwi |
percent change in left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
6 |
post-ischemic value/pre-ischemic value x 100% |
49.57 |
% |
9.45 |
23.14 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46306 |
461 |
FHH-Chr 2BN/Mcwi |
left ventricular developed pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
8 |
|
23.41 |
mmHg |
3.91 |
11.07 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45257 |
461 |
FHH-Chr 2BN/Mcwi |
left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
8 |
|
77.68 |
mmHg |
5.03 |
14.23 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
|
46742 |
461 |
FHH-Chr 2BN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49 days-63 days |
10 |
|
5.21 |
g/kg |
0.19 |
0.6 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46985 |
461 |
FHH-Chr 2BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
6 |
|
10.06 |
ml/min/g |
1.15 |
2.82 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46857 |
461 |
FHH-Chr 2BN/Mcwi |
left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
6 |
|
81.54 |
mmHg |
12.12 |
29.7 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
44802 |
461 |
FHH-Chr 2BN/Mcwi |
percent change in left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
119.64 |
% |
4.94 |
13.98 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
44910 |
461 |
FHH-Chr 2BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
77 days-91 days |
8 |
|
5.95 |
x 1000 cells/ul |
0.55 |
1.56 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39888 |
401 |
FHH-Chr 2BN/Mcwi |
percent change in respiration rate |
air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
10 |
|
134.9 |
% |
8.26 |
26.11 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
53737 |
381 |
FHH-Chr 2BN/Mcwi |
dose of methacholine at which pulmonary conductance is half its pretreatment value |
methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours) |
PhysGen Lung data |
pulmonary ventilation trait |
male |
77 days-91 days |
9 |
|
2.24 |
mg/kg |
0.37 |
1.1 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59168 |
526 |
FHH-Chr 2BN/Mcwi |
left ventricular systolic blood pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
7 |
|
78.91 |
mmHg |
9.3 |
24.6 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49880 |
461 |
FHH-Chr 2BN/Mcwi |
calculated pulmonary vascular resistance normalized to body weight |
Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
8 |
|
0.12 |
mmHg x min x kg x ml-1 |
0.01 |
0.03 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59891 |
526 |
FHH-Chr 2BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77 days-91 days |
7 |
|
131.57 |
mg/dl |
4.85 |
12.83 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41181 |
401 |
FHH-Chr 2BN/Mcwi |
mean corpuscular hemoglobin |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77 days-91 days |
8 |
|
18.73 |
pg |
0.06 |
0.16 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42532 |
401 |
FHH-Chr 2BN/Mcwi |
absolute change in body temperature |
air carbon dioxide content (7 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
female |
82 days-99 days |
10 |
|
0.38 |
degrees C |
0.18 |
0.56 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
15656 |
381 |
FHH-Chr 2BN/Mcwi |
percent change in respiration rate |
air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
10 |
|
120.14 |
% |
7.05 |
22.29 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
53743 |
381 |
FHH-Chr 2BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
10 |
|
131.78 |
breaths/min |
6.18 |
19.55 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18402 |
381 |
FHH-Chr 2BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77 days-91 days |
8 |
|
5.24 |
g/dl |
0.14 |
0.39 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37201 |
401 |
FHH-Chr 2BN/Mcwi |
tidal volume |
air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
10 |
|
0.24 |
ml |
0.02 |
0.07 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
15225 |
381 |
FHH-Chr 2BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
male |
80 days-99 days |
5 |
|
117.94 |
mg/d |
38.55 |
86.21 |
radioimmunoassay |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52412 |
482 |
FHH-Chr 2BN/Mcwi |
respiration rate |
air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
10 |
|
156.24 |
breaths/min |
8.84 |
27.96 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14786 |
381 |
FHH-Chr 2BN/Mcwi |
body temperature |
air carbon dioxide content (7 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
female |
82 days-99 days |
10 |
|
37.53 |
degrees C |
0.12 |
0.38 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
13546 |
381 |
FHH-Chr 2BN/Mcwi |
body temperature |
air carbon dioxide content (7 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
male |
82 days-99 days |
10 |
|
37.57 |
degrees C |
0.17 |
0.53 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
13551 |
381 |
FHH-Chr 2BN/Mcwi |
percent change in ventilation |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
10 |
%change=VE during7-9 min hypercapnia/control during standard conditions |
162.69 |
% |
13.91 |
44.0 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14190 |
381 |
FHH-Chr 2BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
77 days-91 days |
8 |
|
295.13 |
U/l |
6.81 |
19.25 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37453 |
401 |
FHH-Chr 2BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49 days-63 days |
8 |
|
0.72 |
g |
0.03 |
0.07 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49047 |
461 |
FHH-Chr 2BN/Mcwi |
heart contraction pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
male |
49 days-63 days |
8 |
|
29.38 |
mmHg |
2.53 |
7.15 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49989 |
461 |
FHH-Chr 2BN/Mcwi |
serum bicarbonate level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77 days-91 days |
8 |
|
16.25 |
mmol/l |
0.56 |
1.58 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42054 |
401 |
FHH-Chr 2BN/Mcwi |
hematocrit |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77 days-91 days |
8 |
|
56.6 |
% |
1.01 |
2.84 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38983 |
401 |
FHH-Chr 2BN/Mcwi |
mean corpuscular hemoglobin |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77 days-91 days |
8 |
|
18.36 |
pg |
0.08 |
0.21 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42537 |
401 |
FHH-Chr 2BN/Mcwi |
body weight |
air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
body mass |
male |
77 days-91 days |
10 |
|
157.3 |
g |
3.9 |
12.4 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59054 |
526 |
FHH-Chr 2BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77 days-91 days |
8 |
|
103.5 |
mmol/l |
0.53 |
1.51 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40009 |
401 |
FHH-Chr 2BN/Mcwi |
serum phosphate level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77 days-91 days |
7 |
|
10.9 |
mg/dl |
0.35 |
0.94 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37581 |
401 |
FHH-Chr 2BN/Mcwi |
blood hemoglobin level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77 days-91 days |
8 |
|
16.8 |
g/dl |
0.35 |
0.99 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37955 |
401 |
FHH-Chr 2BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77 days-91 days |
8 |
|
61.25 |
U/l |
7.37 |
20.85 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37710 |
401 |
FHH-Chr 2BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77 days-91 days |
8 |
|
1.27 |
g/dl |
0.07 |
0.19 |
standard blood chemistry panel |
|
0 |
|
replaced obsolete serum globulin level term, 1/19/2016 |
Moms and pups used in studies were fed Teklad |
41014 |
401 |
FHH-Chr 2BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
77 days-91 days |
8 |
|
0.01 |
x 1000 cells/ul |
0.01 |
0.03 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41391 |
401 |
FHH-Chr 2BN/Mcwi |
blood eosinophil count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
77 days-91 days |
8 |
|
0.14 |
x 1000 cells/ul |
0.04 |
0.12 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41634 |
401 |
FHH-Chr 2BN/Mcwi |
plasma anion gap |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
77 days-91 days |
8 |
|
22.5 |
mmol/l |
0.57 |
1.6 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38253 |
401 |
FHH-Chr 2BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
9 |
|
-7.78 |
null |
0.08 |
0.25 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
55269 |
522 |
FHH-Chr 2BN/Mcwi |
methylene blue metabolism-surface area product without auto-oxidation |
air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
9 |
|
25.83 |
ml/min/kg |
1.16 |
3.47 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57787 |
526 |
FHH-Chr 2BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
female |
77 days-91 days |
8 |
|
39.51 |
% |
1.32 |
3.73 |
microhematocrit tube assay with visual assessment |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57474 |
526 |
FHH-Chr 2BN/Mcwi |
body temperature |
air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
female |
82 days-99 days |
10 |
|
37.76 |
degrees C |
0.16 |
0.5 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16559 |
381 |
FHH-Chr 2BN/Mcwi |
FAPGG metabolism-surface area product |
air oxygen content (12 %) (for 14 days) then FAPGG (0.6 mmol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
7 |
|
43.98 |
ml/min/kg |
2.01 |
5.31 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57991 |
526 |
FHH-Chr 2BN/Mcwi |
methylene blue to FAPGG metabolism-surface area product ratio |
air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
7 |
|
0.43 |
null |
0.03 |
0.09 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58105 |
526 |
FHH-Chr 2BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
1.72 |
E-7mole |
0.19 |
0.58 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55872 |
522 |
FHH-Chr 2BN/Mcwi |
FAPGG metabolism-surface area product |
FAPGG (0.6 mmol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
9 |
|
77.55 |
ml/min/kg |
8.17 |
24.52 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58214 |
526 |
FHH-Chr 2BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
9 |
|
0.02 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54652 |
522 |
FHH-Chr 2BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
9 |
|
-7.72 |
null |
0.07 |
0.22 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56099 |
522 |
FHH-Chr 2BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
9 |
|
0.02 |
umol/l |
0.01 |
0.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54884 |
522 |
FHH-Chr 2BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
male |
77 days-91 days |
10 |
|
0.55 |
null |
0.04 |
0.12 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58725 |
526 |
FHH-Chr 2BN/Mcwi |
dose of methacholine at which pulmonary conductance is half its pretreatment value |
air oxygen content (12 %) (for 14 days) then methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours) |
PhysGen Lung data |
pulmonary ventilation trait |
female |
77 days-91 days |
8 |
|
2.88 |
mg/kg |
0.7 |
1.97 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58893 |
526 |
FHH-Chr 2BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
2.02 |
E-7mole |
0.37 |
1.1 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
56498 |
522 |
FHH-Chr 2BN/Mcwi |
tidal volume |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
10 |
|
0.35 |
ml |
0.04 |
0.13 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
17362 |
381 |
FHH-Chr 2BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
7 |
|
8.76 |
ml/min/g |
0.66 |
1.74 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46862 |
461 |
FHH-Chr 2BN/Mcwi |
left ventricular systolic blood pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
8 |
|
136.34 |
mmHg |
8.96 |
25.34 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45721 |
461 |
FHH-Chr 2BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
|
9.42 |
ml/min/g |
0.6 |
1.89 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46640 |
461 |
FHH-Chr 2BN/Mcwi |
heart contraction pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
male |
49 days-63 days |
8 |
|
33.25 |
mmHg |
2.82 |
7.98 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48025 |
461 |
FHH-Chr 2BN/Mcwi |
heart weight to body weight ratio |
air oxygen content (12 %) (for 14 days) |
PhysGen Cardiac data |
heart mass |
male |
49 days-63 days |
9 |
|
7.61 |
g/kg |
0.35 |
1.04 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45610 |
461 |
FHH-Chr 2BN/Mcwi |
percent change in heart rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
77.63 |
% |
6.4 |
16.94 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48282 |
461 |
FHH-Chr 2BN/Mcwi |
left ventricular diastolic blood pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
7 |
|
56.31 |
mmHg |
6.03 |
15.96 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46409 |
461 |
FHH-Chr 2BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
3 |
|
0.08 |
IU/g |
0.02 |
0.04 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47300 |
461 |
FHH-Chr 2BN/Mcwi |
percent change in tidal volume |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
|
99.18 |
% |
5.77 |
18.25 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
53869 |
381 |
FHH-Chr 2BN/Mcwi |
left ventricular diastolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
8 |
|
5.61 |
mmHg |
0.23 |
0.66 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49169 |
461 |
FHH-Chr 2BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
10 |
|
116.1 |
breaths/min |
3.87 |
12.23 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18397 |
381 |
FHH-Chr 2BN/Mcwi |
serum alkaline phosphatase activity level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77 days-91 days |
8 |
|
262.0 |
U/l |
8.87 |
25.1 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36366 |
401 |
FHH-Chr 2BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77 days-91 days |
8 |
|
32.59 |
g/dl |
0.25 |
0.7 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37315 |
401 |
FHH-Chr 2BN/Mcwi |
left ventricular diastolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
8 |
|
52.66 |
mmHg |
3.81 |
10.79 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47693 |
461 |
FHH-Chr 2BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
8 |
|
7.1 |
IU/g |
0.77 |
2.19 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45963 |
461 |
FHH-Chr 2BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
7 |
|
4.88 |
ml/min/g |
0.43 |
1.14 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46193 |
461 |
FHH-Chr 2BN/Mcwi |
maximum contractile force per wet weight of aorta |
potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
9 |
|
1.63 |
g/mg |
0.17 |
0.51 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55782 |
522 |
FHH-Chr 2BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
77 days-91 days |
8 |
|
0.09 |
mg/dl |
0.01 |
0.02 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42886 |
401 |
FHH-Chr 2BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77 days-91 days |
8 |
|
3.89 |
x 1000 cells/ul |
0.45 |
1.28 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39872 |
401 |
FHH-Chr 2BN/Mcwi |
serum glucose level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
male |
77 days-91 days |
8 |
|
154.75 |
mg/dl |
2.94 |
8.31 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38522 |
401 |
FHH-Chr 2BN/Mcwi |
percent change in left ventricular developed pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
17.32 |
% |
4.06 |
10.74 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48519 |
461 |
FHH-Chr 2BN/Mcwi |
serum globulin level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
male |
77 days-91 days |
8 |
|
1.65 |
g/dl |
0.12 |
0.33 |
standard blood chemistry panel |
|
0 |
|
replaced obsolete serum globulin level term, 1/19/2016 |
Moms and pups used in studies were fed Teklad |
40542 |
401 |
FHH-Chr 2BN/Mcwi |
methylene blue metabolism-surface area product without auto-oxidation |
methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
9 |
|
28.17 |
ml/min/kg |
2.19 |
6.57 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58610 |
526 |
FHH-Chr 2BN/Mcwi |
methylene blue metabolism-surface area product after auto-oxidation |
air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) then sample resting period (for 0.1 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
9 |
|
11.56 |
ml/min/kg |
0.76 |
2.29 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57590 |
526 |
FHH-Chr 2BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
male |
77 days-91 days |
7 |
|
134.29 |
mg/dl |
2.5 |
6.63 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41197 |
401 |
FHH-Chr 2BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
10 |
|
165.0 |
g |
6.3 |
19.9 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55411 |
522 |
FHH-Chr 2BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
male |
77 days-91 days |
10 |
|
0.28 |
null |
0.01 |
0.05 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57904 |
526 |
FHH-Chr 2BN/Mcwi |
serum potassium level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77 days-91 days |
8 |
|
4.71 |
mmol/l |
0.17 |
0.48 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38053 |
401 |
FHH-Chr 2BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
male |
80 days-99 days |
4 |
|
2.06 |
ml/min |
0.53 |
1.06 |
urine creatinine analysis |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52365 |
482 |
FHH-Chr 2BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
male |
80 days-99 days |
5 |
|
182.24 |
mmHg |
14.91 |
33.34 |
vascular fluid filled catheter |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52557 |
482 |
FHH-Chr 2BN/Mcwi |
minute ventilation |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
10 |
|
54.37 |
ml/min |
6.93 |
21.93 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20753 |
381 |
FHH-Chr 2BN/Mcwi |
percent change in respiration rate |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
10 |
|
132.85 |
% |
7.17 |
22.69 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54203 |
381 |
FHH-Chr 2BN/Mcwi |
tidal volume |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
10 |
|
0.24 |
ml |
0.02 |
0.05 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
13915 |
381 |
FHH-Chr 2BN/Mcwi |
respiration rate |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
10 |
|
143.99 |
breaths/min |
5.38 |
17.01 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
17098 |
381 |
FHH-Chr 2BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77 days-91 days |
8 |
|
208.0 |
U/l |
6.44 |
18.21 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37437 |
401 |
FHH-Chr 2BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77 days-91 days |
8 |
|
9.43 |
mg/dl |
0.24 |
0.69 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36762 |
401 |
FHH-Chr 2BN/Mcwi |
percent change in ventilation |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
10 |
%change=VE during7-9 min hypercapnia/control during standard conditions |
113.59 |
% |
7.67 |
24.24 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18535 |
381 |
FHH-Chr 2BN/Mcwi |
minute ventilation |
air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
|
36.05 |
ml/min |
3.83 |
12.11 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20195 |
381 |
FHH-Chr 2BN/Mcwi |
time to peak heart contraction |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
8 |
|
1161.88 |
s |
40.68 |
115.05 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
50219 |
461 |
FHH-Chr 2BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77 days-91 days |
8 |
|
102.88 |
U/l |
7.3 |
20.65 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42420 |
401 |
FHH-Chr 2BN/Mcwi |
hematocrit |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77 days-91 days |
8 |
|
52.74 |
% |
1.18 |
3.33 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38978 |
401 |
FHH-Chr 2BN/Mcwi |
serum chloride level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77 days-91 days |
8 |
|
108.0 |
mmol/l |
0.82 |
2.33 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39104 |
401 |
FHH-Chr 2BN/Mcwi |
red blood cell count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77 days-91 days |
8 |
|
9.95 |
x 10E6 cells/ul |
0.15 |
0.44 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39229 |
401 |
FHH-Chr 2BN/Mcwi |
serum sodium level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77 days-91 days |
8 |
|
141.75 |
mmol/l |
0.84 |
2.38 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39380 |
401 |
FHH-Chr 2BN/Mcwi |
percent change in respiration rate |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
10 |
|
140.15 |
% |
9.57 |
30.26 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54316 |
381 |
FHH-Chr 2BN/Mcwi |
percent change in tidal volume |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
|
144.65 |
% |
11.0 |
34.78 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54409 |
381 |
FHH-Chr 2BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77 days-91 days |
7 |
|
4.36 |
mmol/l |
0.24 |
0.63 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
43314 |
401 |
FHH-Chr 2BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
male |
77 days-91 days |
7 |
|
4.5 |
mmol/l |
0.11 |
0.29 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
43330 |
401 |
FHH-Chr 2BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77 days-91 days |
8 |
|
17.55 |
pg |
0.08 |
0.23 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40185 |
401 |
FHH-Chr 2BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77 days-91 days |
8 |
|
13.98 |
g/dl |
0.42 |
1.18 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40105 |
401 |
FHH-Chr 2BN/Mcwi |
hematocrit |
air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
female |
77 days-91 days |
8 |
|
52.74 |
% |
1.18 |
3.33 |
microhematocrit tube assay with visual assessment |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59244 |
526 |
FHH-Chr 2BN/Mcwi |
blood hemoglobin level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77 days-91 days |
8 |
|
18.27 |
g/dl |
0.34 |
0.98 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37960 |
401 |
FHH-Chr 2BN/Mcwi |
blood lymphocyte count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77 days-91 days |
8 |
|
5.96 |
x 1000 cells/ul |
1.19 |
3.38 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41490 |
401 |
FHH-Chr 2BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77 days-91 days |
8 |
|
20.25 |
mg/dl |
1.63 |
4.62 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41755 |
401 |
FHH-Chr 2BN/Mcwi |
blood eosinophil count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
77 days-91 days |
8 |
|
0.05 |
x 1000 cells/ul |
0.01 |
0.04 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41639 |
401 |
FHH-Chr 2BN/Mcwi |
heart weight to body weight ratio |
air oxygen content (12 %) (for 14 days) |
PhysGen Cardiac data |
heart mass |
female |
49 days-63 days |
10 |
|
7.62 |
g/kg |
0.31 |
0.97 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45594 |
461 |
FHH-Chr 2BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77 days-91 days |
8 |
|
7.34 |
x 10E6 cells/ul |
0.27 |
0.76 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41956 |
401 |
FHH-Chr 2BN/Mcwi |
mean corpuscular volume |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
77 days-91 days |
8 |
|
58.76 |
fl |
0.32 |
0.92 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38732 |
401 |
FHH-Chr 2BN/Mcwi |
left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
6 |
|
90.92 |
mmHg |
6.66 |
16.32 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45491 |
461 |
FHH-Chr 2BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
9 |
|
0.73 |
g/mg |
0.09 |
0.27 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57328 |
522 |
FHH-Chr 2BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
10 |
|
33.59 |
ml/min |
3.7 |
11.7 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16139 |
381 |
FHH-Chr 2BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
6 |
|
9.1 |
IU/g |
1.59 |
3.89 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48842 |
461 |
FHH-Chr 2BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
7 |
|
6.34 |
IU/g |
1.97 |
5.22 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48853 |
461 |
FHH-Chr 2BN/Mcwi |
methylene blue metabolism-surface area product after auto-oxidation |
air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) then sample resting period (for 0.1 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
9 |
|
13.68 |
ml/min/kg |
0.91 |
2.74 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57585 |
526 |
FHH-Chr 2BN/Mcwi |
FAPGG metabolism-surface area product |
air oxygen content (12 %) (for 14 days) then FAPGG (0.6 mmol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
9 |
|
56.16 |
ml/min/kg |
4.14 |
12.42 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57986 |
526 |
FHH-Chr 2BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
10 |
|
137.6 |
g |
5.4 |
17.2 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55397 |
522 |
FHH-Chr 2BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
|
28.21 |
ml/min |
2.28 |
7.21 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16677 |
381 |
FHH-Chr 2BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
8 |
|
1.39 |
E-7mole |
0.2 |
0.57 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55888 |
522 |
FHH-Chr 2BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
female |
77 days-91 days |
10 |
|
139.0 |
g |
2.2 |
7.1 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58325 |
526 |
FHH-Chr 2BN/Mcwi |
fractional change in blood vessel diameter per unit change in intravascular pressure |
air oxygen content (12 %) (for 14 days) then Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
blood vessel distensibility trait |
male |
77 days-91 days |
9 |
|
0.04 |
mmHg-1 |
0.0 |
0.01 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58481 |
526 |
FHH-Chr 2BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
9 |
|
0.02 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54900 |
522 |
FHH-Chr 2BN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
9 |
|
170.2 |
g |
5.9 |
17.8 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55163 |
522 |
FHH-Chr 2BN/Mcwi |
methylene blue metabolism-surface area product after auto-oxidation |
methylene blue (10 umol/l) (between 0 and 0 hours) then sample resting period (for 0.1 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
8 |
|
13.41 |
ml/min/kg |
1.31 |
3.69 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59997 |
526 |
FHH-Chr 2BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
-6.82 |
null |
0.04 |
0.13 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
56909 |
522 |
FHH-Chr 2BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
79.67 |
% |
4.62 |
13.87 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57202 |
522 |
FHH-Chr 2BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
8 |
|
67.38 |
% |
4.77 |
13.5 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57218 |
522 |
FHH-Chr 2BN/Mcwi |
tidal volume |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
|
0.32 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
17357 |
381 |
FHH-Chr 2BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
8 |
|
10.4 |
ml/min/g |
0.69 |
1.94 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46645 |
461 |
FHH-Chr 2BN/Mcwi |
heart contraction pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
female |
49 days-63 days |
6 |
|
33.33 |
mmHg |
4.6 |
11.27 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48020 |
461 |
FHH-Chr 2BN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49 days-63 days |
8 |
|
5.38 |
g/kg |
0.21 |
0.59 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46969 |
461 |
FHH-Chr 2BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
male |
49 days-63 days |
10 |
|
139.6 |
g |
5.5 |
17.4 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47807 |
461 |
FHH-Chr 2BN/Mcwi |
percent change in heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
6 |
post-ischemic value/pre-ischemic value x 100% |
72.19 |
% |
7.89 |
19.31 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48393 |
461 |
FHH-Chr 2BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
8 |
|
0.54 |
IU/g |
0.2 |
0.57 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47442 |
461 |
FHH-Chr 2BN/Mcwi |
percent change in tidal volume |
air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
|
96.04 |
% |
4.33 |
13.69 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
53970 |
381 |
FHH-Chr 2BN/Mcwi |
percent change in tidal volume |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
10 |
|
125.8 |
% |
7.24 |
22.89 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54075 |
381 |
FHH-Chr 2BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77 days-91 days |
8 |
|
4.35 |
x 1000 cells/ul |
0.44 |
1.23 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36872 |
401 |
FHH-Chr 2BN/Mcwi |
percent change in ventilation |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
%change=VE during 2-3 min hypoxia/control during standard conditions |
145.18 |
% |
11.18 |
35.36 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
13667 |
381 |
FHH-Chr 2BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77 days-91 days |
8 |
|
3.31 |
x 1000 cells/ul |
0.41 |
1.15 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36856 |
401 |
FHH-Chr 2BN/Mcwi |
minute ventilation |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
10 |
|
43.49 |
ml/min |
2.84 |
8.99 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18654 |
381 |
FHH-Chr 2BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
female |
77 days-91 days |
8 |
|
142.88 |
mmol/l |
0.44 |
1.25 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36477 |
401 |
FHH-Chr 2BN/Mcwi |
percent change in heart rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
78.07 |
% |
8.12 |
21.49 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48287 |
461 |
FHH-Chr 2BN/Mcwi |
heart rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
7 |
|
158.11 |
beats/min |
12.95 |
34.27 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45140 |
461 |
FHH-Chr 2BN/Mcwi |
heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
8 |
|
237.98 |
beats/min |
6.42 |
18.16 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48189 |
461 |
FHH-Chr 2BN/Mcwi |
percent change in heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
73.34 |
% |
4.6 |
13.01 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48398 |
461 |
FHH-Chr 2BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
9 |
|
7.47 |
IU/g |
1.32 |
3.96 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45953 |
461 |
FHH-Chr 2BN/Mcwi |
FAPGG metabolism-surface area product |
FAPGG (0.6 mmol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
8 |
|
61.22 |
ml/min/kg |
4.78 |
13.52 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58230 |
526 |
FHH-Chr 2BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77 days-91 days |
8 |
|
91.0 |
mg/dl |
3.59 |
10.14 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38436 |
401 |
FHH-Chr 2BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
77 days-91 days |
8 |
|
17.63 |
mg/dl |
1.08 |
3.07 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41739 |
401 |
FHH-Chr 2BN/Mcwi |
time to onset of heart contraction |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
male |
49 days-63 days |
8 |
|
950.88 |
s |
32.21 |
91.11 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49291 |
461 |
FHH-Chr 2BN/Mcwi |
heart left ventricle infarction weight to total heart left ventricle weight ratio |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours) |
PhysGen Cardiac data |
heart left ventricle integrity trait |
male |
49 days-63 days |
7 |
|
9.12 |
% |
1.74 |
4.61 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49690 |
461 |
FHH-Chr 2BN/Mcwi |
time to peak heart contraction |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
8 |
|
1188.0 |
s |
23.23 |
65.69 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46540 |
461 |
FHH-Chr 2BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77 days-91 days |
8 |
|
17.29 |
pg |
0.07 |
0.19 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40201 |
401 |
FHH-Chr 2BN/Mcwi |
heart contraction pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
female |
49 days-63 days |
10 |
|
25.6 |
mmHg |
1.97 |
6.24 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49984 |
461 |
FHH-Chr 2BN/Mcwi |
serum globulin level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77 days-91 days |
8 |
|
1.5 |
g/dl |
0.07 |
0.2 |
standard blood chemistry panel |
|
0 |
|
replaced obsolete serum globulin level term, 1/19/2016 |
Moms and pups used in studies were fed Teklad |
40537 |
401 |
FHH-Chr 2BN/Mcwi |
calculated pulmonary vascular resistance normalized to body weight |
Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
9 |
|
0.09 |
mmHg x min x kg x ml-1 |
0.0 |
0.01 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59875 |
526 |
FHH-Chr 2BN/Mcwi |
red blood cell count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77 days-91 days |
8 |
|
8.98 |
x 10E6 cells/ul |
0.18 |
0.51 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39224 |
401 |
FHH-Chr 2BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
77 days-91 days |
8 |
|
0.31 |
mg/dl |
0.04 |
0.1 |
automated plasma creatinine analysis |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42633 |
401 |
FHH-Chr 2BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
77 days-91 days |
8 |
|
0.25 |
mg/dl |
0.03 |
0.08 |
automated plasma creatinine analysis |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42649 |
401 |
FHH-Chr 2BN/Mcwi |
absolute change in body temperature |
air carbon dioxide content (7 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
male |
82 days-99 days |
10 |
|
0.19 |
degrees C |
0.1 |
0.31 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
15661 |
381 |
FHH-Chr 2BN/Mcwi |
percent change in respiration rate |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
10 |
|
133.54 |
% |
8.32 |
26.31 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54209 |
381 |
FHH-Chr 2BN/Mcwi |
percent change in ventilation |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
10 |
%change=VE during 2-3 min hypoxia/control during standard conditions |
137.56 |
% |
8.88 |
28.09 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
13672 |
381 |
FHH-Chr 2BN/Mcwi |
serum total protein level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77 days-91 days |
8 |
|
5.28 |
g/dl |
0.08 |
0.23 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36954 |
401 |
FHH-Chr 2BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
10 |
|
0.29 |
ml |
0.02 |
0.07 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
15389 |
381 |
FHH-Chr 2BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
female |
80 days-99 days |
5 |
|
156.33 |
mmHg |
11.05 |
24.71 |
vascular fluid filled catheter |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52538 |
482 |
FHH-Chr 2BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
female |
80 days-99 days |
5 |
|
419.9 |
beats/min |
8.37 |
18.73 |
vascular fluid filled catheter |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52491 |
482 |
FHH-Chr 2BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
female |
80 days-99 days |
6 |
|
0.87 |
mEq/d |
0.13 |
0.32 |
flame atomic emission spectrometry |
|
0 |
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52299 |
482 |
FHH-Chr 2BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
female |
80 days-99 days |
5 |
|
1.71 |
ml/min |
0.2 |
0.44 |
urine creatinine analysis |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52346 |
482 |
FHH-Chr 2BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
male |
80 days-99 days |
4 |
|
1.73 |
ng/ml/h |
0.23 |
0.46 |
radioimmunoassay |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52904 |
482 |
FHH-Chr 2BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
|
0.24 |
ml |
0.02 |
0.05 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
17969 |
381 |
FHH-Chr 2BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
female |
82 days-99 days |
10 |
|
154.4 |
g |
5.6 |
17.7 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Dyets |
17804 |
381 |
FHH-Chr 2BN/Mcwi |
respiration rate |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
10 |
|
148.85 |
breaths/min |
3.99 |
12.61 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16898 |
381 |
FHH-Chr 2BN/Mcwi |
minute ventilation |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
|
40.62 |
ml/min |
4.8 |
15.17 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18649 |
381 |
FHH-Chr 2BN/Mcwi |
heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
8 |
|
173.3 |
beats/min |
8.93 |
25.25 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48937 |
461 |
FHH-Chr 2BN/Mcwi |
respiration rate |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
10 |
|
180.21 |
breaths/min |
6.05 |
19.13 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18257 |
381 |
FHH-Chr 2BN/Mcwi |
minute ventilation |
air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
10 |
|
36.64 |
ml/min |
3.36 |
10.64 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20200 |
381 |
FHH-Chr 2BN/Mcwi |
left ventricular diastolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
6 |
|
4.94 |
mmHg |
0.27 |
0.66 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49164 |
461 |
FHH-Chr 2BN/Mcwi |
body weight |
air oxygen content (12 %) (for 14 days) |
PhysGen Cardiac data |
body mass |
male |
49 days-63 days |
9 |
|
114.8 |
g |
6.4 |
19.3 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49512 |
461 |
FHH-Chr 2BN/Mcwi |
serum chloride level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77 days-91 days |
8 |
|
109.0 |
mmol/l |
1.1 |
3.12 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39109 |
401 |
FHH-Chr 2BN/Mcwi |
serum albumin level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
female |
77 days-91 days |
8 |
|
3.36 |
g/dl |
0.09 |
0.24 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42220 |
401 |
FHH-Chr 2BN/Mcwi |
serum aspartate aminotransferase activity level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77 days-91 days |
8 |
|
79.25 |
U/l |
3.31 |
9.36 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42757 |
401 |
FHH-Chr 2BN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
female |
77 days-91 days |
8 |
|
18.0 |
mmol/l |
2.58 |
7.29 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
43118 |
401 |
FHH-Chr 2BN/Mcwi |
blood neutrophil count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
77 days-91 days |
8 |
|
1.35 |
x 1000 cells/ul |
0.15 |
0.44 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
43216 |
401 |
FHH-Chr 2BN/Mcwi |
percent change in respiration rate |
air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
10 |
|
147.99 |
% |
11.65 |
36.84 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54310 |
381 |
FHH-Chr 2BN/Mcwi |
percent change in tidal volume |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
10 |
|
120.91 |
% |
6.36 |
20.1 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54415 |
381 |
FHH-Chr 2BN/Mcwi |
blood monocyte count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
female |
77 days-91 days |
8 |
|
0.3 |
x 1000 cells/ul |
0.08 |
0.21 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39661 |
401 |
FHH-Chr 2BN/Mcwi |
blood monocyte count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
male |
77 days-91 days |
8 |
|
0.29 |
x 1000 cells/ul |
0.07 |
0.19 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39666 |
401 |
FHH-Chr 2BN/Mcwi |
plasma creatinine level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
77 days-91 days |
8 |
|
0.33 |
mg/dl |
0.03 |
0.07 |
automated plasma creatinine analysis |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39568 |
401 |
FHH-Chr 2BN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
female |
77 days-91 days |
8 |
|
0.17 |
x 1000 cells/ul |
0.04 |
0.11 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40281 |
401 |
FHH-Chr 2BN/Mcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
male |
77 days-91 days |
8 |
|
3.74 |
g/dl |
0.08 |
0.23 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40410 |
401 |
FHH-Chr 2BN/Mcwi |
percent change in respiration rate |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
10 |
|
137.84 |
% |
7.63 |
24.11 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
53618 |
381 |
FHH-Chr 2BN/Mcwi |
serum urea nitrogen level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
77 days-91 days |
8 |
|
21.0 |
mg/dl |
1.05 |
2.98 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40815 |
401 |
FHH-Chr 2BN/Mcwi |
serum urea nitrogen level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77 days-91 days |
8 |
|
27.88 |
mg/dl |
1.33 |
3.76 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40820 |
401 |
FHH-Chr 2BN/Mcwi |
total white blood cell count |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
77 days-91 days |
8 |
|
6.86 |
x 1000 cells/ul |
0.76 |
2.16 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40918 |
401 |
FHH-Chr 2BN/Mcwi |
serum alanine aminotransferase activity level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
77 days-91 days |
8 |
|
36.25 |
U/l |
2.4 |
6.8 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40701 |
401 |
FHH-Chr 2BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
female |
77 days-91 days |
10 |
|
1.1 |
g/kg |
0.03 |
0.09 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59441 |
526 |
FHH-Chr 2BN/Mcwi |
calculated pulmonary vascular resistance normalized to body weight |
air oxygen content (12 %) (for 14 days) then Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
9 |
|
0.18 |
mmHg x min x kg x ml-1 |
0.01 |
0.02 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59539 |
526 |
FHH-Chr 2BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
77 days-91 days |
8 |
|
0.07 |
x 1000 cells/ul |
0.04 |
0.13 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41407 |
401 |
FHH-Chr 2BN/Mcwi |
lung dry weight to body weight ratio |
air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
lung mass |
male |
77 days-91 days |
10 |
|
1.56 |
g/kg |
0.04 |
0.13 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59649 |
526 |
FHH-Chr 2BN/Mcwi |
methylene blue to FAPGG metabolism-surface area product ratio |
methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
8 |
|
0.38 |
null |
0.01 |
0.03 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59776 |
526 |
FHH-Chr 2BN/Mcwi |
serum glucose level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77 days-91 days |
7 |
|
173.14 |
mg/dl |
7.77 |
20.56 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38517 |
401 |
FHH-Chr 2BN/Mcwi |
time to peak heart contraction |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
6 |
|
1198.67 |
s |
57.22 |
140.15 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46535 |
461 |
FHH-Chr 2BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
9 |
|
1.37 |
g/mg |
0.26 |
0.78 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57312 |
522 |
FHH-Chr 2BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
9 |
|
-7.7 |
null |
0.07 |
0.21 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
55253 |
522 |
FHH-Chr 2BN/Mcwi |
methylene blue metabolism-surface area product without auto-oxidation |
air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
9 |
|
19.42 |
ml/min/kg |
1.04 |
3.13 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57792 |
526 |
FHH-Chr 2BN/Mcwi |
percent change in left ventricular systolic blood pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
59.59 |
% |
6.15 |
16.26 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48748 |
461 |
FHH-Chr 2BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
|
24.97 |
ml/min |
2.03 |
6.42 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16134 |
381 |
FHH-Chr 2BN/Mcwi |
tidal volume |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
10 |
|
0.36 |
ml |
0.04 |
0.13 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16465 |
381 |
FHH-Chr 2BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
10 |
|
32.81 |
ml/min |
2.91 |
9.21 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16682 |
381 |
FHH-Chr 2BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
-6.79 |
null |
0.05 |
0.15 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55603 |
522 |
FHH-Chr 2BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82 days-99 days |
10 |
|
37.47 |
degrees C |
0.16 |
0.5 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16799 |
381 |
FHH-Chr 2BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82 days-99 days |
10 |
|
37.26 |
degrees C |
0.2 |
0.65 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16804 |
381 |
FHH-Chr 2BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
69.22 |
% |
5.23 |
15.68 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54758 |
522 |
FHH-Chr 2BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
69.67 |
% |
3.25 |
9.75 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54774 |
522 |
FHH-Chr 2BN/Mcwi |
methylene blue metabolism-surface area product after auto-oxidation |
methylene blue (10 umol/l) (between 0 and 0 hours) then sample resting period (for 0.1 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
9 |
|
16.29 |
ml/min/kg |
1.09 |
3.27 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59981 |
526 |
FHH-Chr 2BN/Mcwi |
arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
|
3.16 |
ml/min/g |
0.52 |
1.55 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
44705 |
461 |
FHH-Chr 2BN/Mcwi |
percent change in left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
59.92 |
% |
2.85 |
8.05 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46311 |
461 |
FHH-Chr 2BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
6 |
|
5.44 |
ml/min/g |
0.54 |
1.32 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46188 |
461 |
FHH-Chr 2BN/Mcwi |
heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
6 |
|
170.01 |
beats/min |
14.43 |
35.35 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48932 |
461 |
FHH-Chr 2BN/Mcwi |
percent change in tidal volume |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
|
145.64 |
% |
10.98 |
34.72 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54069 |
381 |
FHH-Chr 2BN/Mcwi |
serum total protein level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
female |
77 days-91 days |
8 |
|
4.86 |
g/dl |
0.08 |
0.21 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36949 |
401 |
FHH-Chr 2BN/Mcwi |
serum total cholesterol level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
77 days-91 days |
8 |
|
59.63 |
mg/dl |
2.93 |
8.3 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37084 |
401 |
FHH-Chr 2BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
female |
77 days-91 days |
8 |
|
9.68 |
mg/dl |
0.22 |
0.63 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36746 |
401 |
FHH-Chr 2BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82 days-99 days |
10 |
|
37.15 |
degrees C |
0.19 |
0.59 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
19056 |
381 |
FHH-Chr 2BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
male |
80 days-99 days |
5 |
|
393.33 |
mg/d |
89.68 |
200.53 |
automated urine total protein analysis |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52120 |
482 |
FHH-Chr 2BN/Mcwi |
left ventricular diastolic blood pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
8 |
|
53.91 |
mmHg |
4.94 |
13.96 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46404 |
461 |
FHH-Chr 2BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
10 |
|
0.25 |
IU/g |
0.04 |
0.12 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47426 |
461 |
FHH-Chr 2BN/Mcwi |
left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
6 |
|
85.99 |
mmHg |
6.81 |
16.68 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
|
46737 |
461 |
FHH-Chr 2BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
8 |
|
-6.89 |
null |
0.07 |
0.19 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55619 |
522 |
FHH-Chr 2BN/Mcwi |
heart left ventricle infarction weight to total heart left ventricle weight ratio |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours) |
PhysGen Cardiac data |
heart left ventricle integrity trait |
female |
49 days-63 days |
6 |
|
5.06 |
% |
3.11 |
7.61 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49383 |
461 |
FHH-Chr 2BN/Mcwi |
serum total bilirubin level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
77 days-91 days |
8 |
|
0.18 |
mg/dl |
0.02 |
0.05 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41855 |
401 |
FHH-Chr 2BN/Mcwi |
serum total bilirubin level |
air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
77 days-91 days |
8 |
|
0.13 |
mg/dl |
0.02 |
0.05 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41860 |
401 |
FHH-Chr 2BN/Mcwi |
left ventricular developed pressure |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
8 |
|
112.43 |
mmHg |
9.17 |
25.93 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48611 |
461 |
FHH-Chr 2BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77 days-91 days |
10 |
|
0.56 |
null |
0.04 |
0.13 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58720 |
526 |
FHH-Chr 2BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
77 days-91 days |
8 |
|
0.4 |
x 1000 cells/ul |
0.09 |
0.25 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38883 |
401 |
FHH-Chr 2BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
1.57 |
E-7mole |
0.17 |
0.5 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
56514 |
522 |
FHH-Chr 2BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
male |
77 days-91 days |
8 |
|
1.5 |
g/dl |
0.06 |
0.18 |
standard blood chemistry panel |
|
0 |
|
replaced obsolete serum globulin level term, 1/19/2016 |
Moms and pups used in studies were fed Teklad |
41030 |
401 |
FHH-Chr 2BN/Mcwi |
calculated pulmonary vascular resistance normalized to body weight |
air oxygen content (12 %) (for 14 days) then Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
9 |
|
0.17 |
mmHg x min x kg x ml-1 |
0.01 |
0.02 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59534 |
526 |